Parents with teething infants should not use “gum-numbing” anesthetics known as viscous lidocaine, the U.S. Food and Drug Administration (FDA) recently reported. When used among infants and young children, such medications can…
read moreThe Firm pharmaceutical lawyers are dedicated to providing you with the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls, approvals and warning…
read moreThe US Food and Drug Administration (FDA), announced last week that there has been another risk associated with testosterone treatments. The FDA is now requiring manufacturers of testosterone or low T products must…
read moreThe U.S. Judicial Panel on Multidistrict Litigation has ordered the consolidation of all federal testosterone therapy lawsuits before the Hon. Matthew F. Kennelly in the Northern District of Illinois, U.S. District Court.…
read moreThe pharmaceutical lawyers at the Firm are committed to keeping you up-to-date on the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls,…
read moreOur dedication to customer service, our national resources, and our cumulative centuries of legal experience are what drives our results.
make an appointment